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Chorioamnionitis induces hepatic 
inflammation and time‑dependent 
changes of the enterohepatic 
circulation in the ovine fetus
Cathelijne Heymans1, Marcel den Dulk2,3, Kaatje Lenaerts1, Lara R. Heij1,3,4, 
Ilse H. de Lange1,5, Mhamed Hadfoune1, Chantal van Heugten1, Boris W. Kramer5,6, 
Alan H. Jobe7,8, Masatoshi Saito7,9, Matthew W. Kemp7,10, Tim G. A. M. Wolfs5,11* & 
Wim G. van Gemert1,2,3
Chorioamnionitis, inflammation of fetal membranes, is an important cause of preterm birth and a risk 
factor for the development of adverse neonatal outcomes including sepsis and intestinal pathologies. 
Intestinal bile acids (BAs) accumulation and hepatic cytokine production are involved in adverse 
intestinal outcomes. These findings triggered us to study the liver and enterohepatic circulation (EHC) 
following intra‑amniotic (IA) lipopolysaccharide (LPS) exposure. An ovine chorioamnionitis model 
was used in which circulatory cytokines and outcomes of the liver and EHC of preterm lambs were 
longitudinally assessed following IA administration of 10 mg LPS at 5, 12 or 24h or 2, 4, 8 or 15d before 
preterm birth. Hepatic inflammation was observed, characterized by increased hepatic cytokine 
mRNA levels (5h – 2d post IA LPS exposure) and increased erythropoietic clusters (at 8 and 15 days 
post IA LPS exposure). Besides, 12h after IA LPS exposure, plasma BA levels were increased, whereas 
gene expression levels of several hepatic BA transporters were decreased. Initial EHC alterations 
normalized over time. Concluding, IA LPS exposure induces significant time‑dependent changes in the 
fetal liver and EHC. These chorioamnionitis induced changes have potential postnatal consequences 
and the duration of IA LPS exposure might be essential herein.
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GAPDH  Glyceraldehyde 3-phosphate dehydrogenase
IA  Intra-amniotic
IBA1  Ionized calcium binding adaptor molecule 1
IBABP  Ileal bile acid-binding protein
IL  Interleukin
IQR  Interquartile range
LPS  Lipopolysaccharide
NEC  Necrotizing enterocolitis
NTCP  Na + -taurocholate cotransporting polypeptide
OSTα  Organic solute transporter alpha
OSTβ  Organic solute transporter bèta
PPIA  Peptidylprolyl isomerase A
qPCR  Quantitative real-time PCR
RPS15  Ribosomal protein S15
tBAs  Total bile acids
TNF-α  Tumor necrosis factor alpha
Premature birth, before 37 weeks of gestation, is a major cause of morbidity and mortality among infants 
 worldwide1. Chorioamnionitis, inflammation of the chorion and amnion during pregnancy, resulting from an 
ascending bacterial infection through the birth canal, is associated with premature  birth2–4. During chorioam-
nionitis, the fetus can develop the fetal inflammatory response syndrome (FIRS), characterized by increased 
fetal systemic IL-6 and IL-8  levels5. Chorioamnionitis, prematurity and FIRS can contribute to significant rates 
of neonatal morbidity and mortality and are associated with the development of adverse neonatal outcomes 
including early-onset sepsis and intestinal  pathologies6–9.
Sepsis-associated cholestasis is a common complication in infants and is commonly caused by lipopolysaccha-
ride (LPS), derived from Gram negative  bacteria10. This inflammation-induced cholestasis results from a reduced 
mRNA expression of various hepatic bile acid (BA) transporters, such as the  Na+-taurocholate cotransporting 
polypeptide (NTCP) and the bile salt export pump (BSEP)10. In specific, LPS activates cytokine production of 
Kupffer cells such as tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β). These cytokines bind 
to their receptors on hepatocytes that activates an intracellular signaling cascade resulting in altered nuclear 
transcription factors and reduced mRNA  expression10. Cholestasis can lead to hepatocyte injury as BAs have 
been shown to be hepatotoxic during  cholestasis11. Several mechanisms may account for this hepatotoxity; BAs 
could disrupt cell membranes through their detergent action on lipid components and also promote the genera-
tion of reactive oxygen species that oxidatively modify lipids, proteins and nucleic acids, which eventually cause 
hepatocyte necrosis and  apoptosis11.
The liver and intestine are closely connected via the enterohepatic circulation (EHC) of BAs. In line, BAs are 
recently found to be critical regulators of intestinal epithelial  function12. Several studies have found that elevated 
ileal BAs and an altered expression of several BAs transporters may result in ileal damage, contributing to the 
development of necrotizing enterocolitis (NEC). More precisely, full necrosis in the ileum was found in rats as 
the result of intraluminal accumulation of conjugated BAs, which was similar to the histopathological findings 
in an experimental rat NEC  model13,14. Increased BA synthesis might be the cause of these elevated intraluminal 
BAs  concentrations15. In addition, preterm infants with NEC and rodents with induced NEC were found to have 
an increased expression of the apical sodium-dependent bile acid transporter (ASBT), a protein involved in 
intestinal BAs uptake, suggesting increased BAs uptake by  enterocytes14,16. In addition, an insufficient transport 
from the apical to basolateral side of the enterocyte was suggested since rats with induced NEC had a decreased 
expression of ileal bile acid-binding protein (IBABP) in their  ileum14. Altogether, this results in BAs accumulation 
within enterocytes, with concomitant enterocyte  damage17, resulting from similar mechanisms as in cholestasis 
induced hepatocyte  injury11. The production of hepatic cytokines was increased in neonatal rats with induced 
NEC and this correlated with the progression of intestinal damage during NEC  development18, which further 
underlines the important role of the gut-liver axis in NEC pathogenesis.
Fecal BA levels were found to be higher in preterm infants in the week preceding NEC manifestation com-
pared with gestation matched  controls17. Moreover, it was shown that fetuses exposed to endotoxin-induced 
chorioamnionitis develop hepatic inflammation and a disturbed lipid metabolism in  utero19, which may persist 
into  adolescence20. These combined findings suggest that the mentioned earlier liver and EHC alterations might 
already have their origin in utero.
Recent research showed that the fetal liver is an active immune organ with the ability of inducing an early and 
robust innate immune response activation, and immune activation is already initiated within 1 h to 5 h after an 
in utero inflammatory  challenge21. The changes during intra-uterine infection, including liver inflammation and 
EHC alterations, are likely to be time-dependent as inflammation is a dynamic process and the vulnerability of 
the fetus to injurious hits during the complex intra-uterine development varies. The aim of this study is, given 
the involvement of the liver in sepsis and adverse gastro-intestinal outcomes, to evaluate the time-dependent 
effects of intra-uterine administration of one bolus of LPS from 15 days to 5 hours before premature delivery, 
on the liver and EHC of premature sheep.
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Materials and methods
Animal model and experimental procedures. This animal study was performed in Australia and the 
experiments were approved by the Animal Ethics Committees at The University of Western Australia (Perth, 
Australia; permit number: RA/3/100/928). Our study was carried out in compliance with the ARRIVE guide-
lines.
The original ovine model and experimental design were previously  published5,22–24. In short, date-mated 
merino ewes pregnant with singleton fetuses were randomly assigned to eight different groups. After dropout 
or exclusion (fetuses in the control group with extremely high systemic IL-6 and/or IL-8 levels), the different 
groups consisted of 6 to 7 animals per group. The pregnant ewes received a single intra-amniotic (IA) injection 
under ultrasound guidance of 10 mg Escherichia coli-derived lipopolysaccharide (LPS) (O55:B5; Sigma-Aldrich, 
St. Louis, MO, USA) dissolved in saline. These injections were given at 5, 12 or 24 hours or 2, 4, 8 or 15 days 
before preterm delivery at 125 days of gestation (corresponds with 30–32 weeks of human gestation; term gesta-
tion in sheep is around 150 days). The control group received IA injections of saline at variable gestational ages 
comparable to the time points of the LPS injections before preterm delivery (Fig. 1).
The preterm lambs were delivered by cesarean section at 125 days of gestation and euthanized with intrave-
nous pentobarbital (100 mg/kg). During necropsy, blood, liver and terminal ileum samples were sampled. Liver 
and ileum samples were fixed in paraformaldehyde and subsequently embedded in paraffin or liver and ileum 
samples were snap frozen in nitrogen.
Qualitative analysis of liver histology. A Hematoxylin and Eosin (H&E) staining was performed which 
an independent pathologist blinded to the experimental set-up analyzed as previously  described25. In short, 
the slides were qualitatively scored pathologically on a 0 to 4 scale for hepatic sinusoidal dilatation, shape and 
size of central veins and number and location of extramedullary hematopoietic clusters. Animals that had been 
assigned with scoring 0 had no sinusoidal dilatation, no divergent shape or size of central veins and no altered 
extramedullary hematopoietic clusters. Animals that had been assigned with scoring 4 had pronounced sinusoi-
dal dilatation throughout the parenchyma, large central veins with venous stowing throughout the parenchyma 
and a severely increased pathologic score of extramedullary hematopoietic clusters. An increased pathologic 
score of extramedullary hematopoiesis, reflecting clustered and conflated hepatic erythropoiesis in the paren-
chyma, is a hallmark of increased erythropoiesis as a response to  inflammation26.
Total bile acid assay. As previously  described25, total bile acids (tBAs) were measured in plasma, liver 
homogenate and terminal ileum homogenate by an enzymatic cycling method, according to the manufacture 
protocol (Total Bile Acids Assay kit, Diazyme Laboratories, Poway, CA, USA). tBAs in liver and ileum homoge-
nate were corrected for protein content, which were measured with a BCA protein assay kit (Thermo Fisher 
Scientific, Waltham, MA, USA).
RNA extraction and real‑time PCR. RNA extraction and quantitative real-time polymerase chain reac-
tion (qPCR) was performed as previously  described25. In short, RNA was extracted from snap frozen liver and 
terminal ileal tissue using TRI reagent (Thermo Fisher Scientific)/chloroform extraction. Hereafter, with the use 
of a sensifast cDNA Synthesis kit (Bioline, London, UK), RNA was reverse transcribed into cDNA. With the 
specific primer in Sensimix SYBR & Fluorescein Kit (Bioline), a qPCR was performed using a 384-wells qPCR 
plate. qPCR reactions were executed in a LightCycler 480 Instrument (Roche Applied Science, Basel, Switzer-
land) for 45 cycles. mRNA expression levels of tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-
1β), interleukin-8 (IL-8) and interleukin-18 (IL-18) were measured to assess liver inflammation. IL-18 mRNA 
expression was also measured in ileal samples to asses ileal inflammation. Gene expression levels of cholesterol 7 
alpha-hydroxylase (CYP7A1), cytochrome P450 family 27 subfamily A member 1 (CYP27A1),  Na+-taurocholate 
cotransporting polypeptide (NTCP), bile salt export pump (BSEP), apical sodium–dependent bile acid trans-
porter (ASBT), fibroblast growth factor 19 (FGF19), ileal bile acid-binding protein (IBABP) and organic solute 
transporter alpha–beta (OSTα-β) were measured to assess alterations in the EHC of BAs. To calculate the mRNA 
expression levels, LinRegPCR software (version 2016.0, Heart Failure Research Center, Academic Medical 
Center, Amsterdam, the Netherlands) was used. The geometric mean of the expression levels of three reference 
genes (ribosomal protein S15 (RPS15), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and peptidylpro-
lyl isomerase A (PPIA)) was calculated and used as a normalization factor. Data are shown as fold increase over 
the control value; arbitrary unit (AU). Primer sequences are displayed in Table 1.
Figure 1.  Study design. At 5, 12, or 24 hours or 2, 4, 8 or 15 days (black arrows) pregnant ewes received an 
IA injection with 10 mg LPS before preterm delivery at 125 days of gestation (term ~ 150 days). An IA saline 
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Immunohistochemistry. Staining of ionized calcium binding adaptor molecule 1 (IBA1), a macrophage 
marker, in the terminal ileum was used as a marker for intestinal inflammation. For immunohistochemistry, the 
following antibodies were used: polyclonal rabbit anti-rat IBA1 (019-19,741; Fujifilm Wako Chemicals Europe, 
Neuss, Germany) and polyclonal swine anti-rabbit biotin (E0353; DakoCytomation, Glostrup, Denmark). After 
4% paraformaldehyde fixation and paraffin embedding 4 µm thick sections were cut. Following rehydration, 
endogenous peroxidase activity was blocked by incubating sections for 20 min in 0.3%  H2O2 dissolved in phos-
phatase buffered saline. Antigen retrieval was performed by boiling the slides in 10 mM sodium citrate buffer 
(pH 6.0). Thereafter, aspecific binding sites were blocked by incubating the sections with 4% normal goat serum 
and sections were incubated with the primary antibody overnight at 4 °C. Subsequently, sections were incubated 
with biotin-conjugated secondary antibody for 1 h at room temperature. IBA1 positive cells were detected with 
3,3ʹ-diaminobenzidine ([DAB]; Sigma Aldrich, St Louis, MO, USA). IBA1 immunoreactivity (IBA1 positive 
surface area) was detected and corrected for ileal surface area with the use of Qwin Pro software (v3.4.0, Leica 
Microsystem, Wetzlar, Germany). IBA1 immunoreactivity is depicted as the percentage of ileal surface area 
positively stained for IBA1.
Data analysis. Data are presented as median with interquartile range (IQR). Statistical analyses were car-
ried out with GraphPad Prism (version 6.01, GraphPad Software Inc., La Jolla, CA, USA). To analyze significant 
differences between the groups, a nonparametric Kruskal–Wallis test followed by Dunn’s post hoc test was per-
formed. At P ≤ 0.05, differences were considered statistically significant. Given the small study groups and the 
potential biological relevance, differences with a P < 0.10 are also taken into account, and described as tendencies 
as previously  described27. This assumption will increase the chance of a type I error, but will decrease the chance 
of a type II error.
Results
Severe liver inflammation at day 8 and day 15 after IA LPS administration. Histologically, no 
sinusoidal dilatation or divergent shape or size of central veins was observed in any of the groups. An increased 
qualitative pathological score of extramedullary hematopoiesis was observed in the liver of animals 8 days and 
15 days after LPS administration, compared to control (both P < 0.05; Fig. 2A–D) reflecting clustered and con-
flated hepatic erythropoiesis in the parenchyma (Fig. 2B,C).
Hepatic IL-8 mRNA levels tended to be increased 5 hours after IA LPS administration, compared to control 
(P = 0.09; Fig. 3A). Furthermore, TNF-α mRNA levels tended to be increased 12 hours after IA LPS, compared 
to control (P = 0.07; Fig. 3B). Moreover, IL-18 mRNA levels were increased 24 hours and 2 days after IA LPS 
administration (both P ≤ 0.05; Fig. 3C). Hepatic IL-1β mRNA levels did not differ between the groups (Sup-
plementary Figure S1).
Enterohepatic circulation alterations due to IA LPS exposure. Gene expression of NTCP, the 
transporter responsible for BAs uptake from the portal circulation into the hepatocyte, was decreased in the 
liver of animals at 12 hours after IA LPS administration, compared to control (P < 0.05; Fig. 4a). In addition, 
gene expression of BSEP, the pump responsible for BAs excretion from the hepatocyte into the bile canaliculi for 
export into the gastrointestinal tract, was also decreased in the liver of animals at 12 hours after IA LPS admin-
istration (P < 0.05; Fig. 4b).
In addition, plasma tBAs concentrations were increased in animals 12 hours after IA LPS administration, 
compared to control (P < 0.05; Fig. 5). Furthermore, tBAs concentrations in liver and ileum homogenates did 
Table 1.  Primer sequences.
Primer Forward Reverse
RPS15 5ʹ-CGA GAT GGT GGG CAG CAT -3ʹ 5ʹ-GCT TGA TTT CCA CCT GGT TGA-3ʹ
GAPDH 5ʹ-GGA AGC TCA CTG GCA TGG C-3ʹ 5ʹ-CCT GCT TCA CCA CCT TCT TG-3ʹ
PPIA 5ʹ-TTA TAA AGG TTC CTG CTT TCA CAG AA-3ʹ 5ʹ-ATG GAC TTG CCA CCA GTA CCA-3ʹ
TNF-α 5ʹ-CAT CTT CTC AAG CCT CAA ATA ACA A-3ʹ 5ʹ-TGC GAG TAG ATG AGG TAA AGCCC-3ʹ
IL-1β 5ʹ-AGA ATG AGC TGT TAT TTG AGG TTG ATG-3ʹ 5ʹ-GTG AGA AAT CTG CAG CTG GATGT-3ʹ
IL-8 5ʹ-GTT CCA AGC TGG CTG TTG CT-3ʹ 5ʹ-GTG GAA AGG TGT GGA ATG TGTTT-3ʹ
IL-18 5ʹ-AAG GGG CTG CCG TCT TCT AT-3ʹ 5ʹ-GAT CTG ATT CCA GGT CGC CAT-3ʹ
CYP7A1 5ʹ-GGG CAT CAC AAG CAA ACA CC-3ʹ 5ʹ-GAT GAT ACT GTC TAG CAC GGG-3ʹ
CYP27A1 5ʹ-CCC AAG AAT ACC CAG TTT GTGC-3ʹ 5ʹ-GGT GGC AGA AGA CTC AGT TCA-3ʹ
NTCP 5ʹ-TCC TCA AAT CCA AAC GGC CA-3ʹ 5ʹ-GTT TGG ATC GTC CAT TGA GGC-3ʹ
BSEP 5ʹ-ACT CAG TAA TTC TTC GCA GTGTG-3ʹ 5ʹ-ATC GAA ACA ATC GAA AGA AGCCA-3ʹ
ASBT 5ʹ-CAT GGA CCT GAG CGT CAG CAT-3ʹ 5ʹ-CAC GGA GAC GGG AAC AAC AA-3ʹ
FGF19 5ʹ-TTG ATG GAG ATC AGG GCG GT-3ʹ 5ʹ-CGG ATC TCC TCC TCG AAA GC-3ʹ
IBABP 5ʹ-ACA AGA AGT TCA AGG TCA CCG-3ʹ 5ʹ-TGA TAC GGC TTT ATG GCC CC-3ʹ
OSTα 5ʹ-ATC CCA GGT ACA CGG CAG AT-3ʹ 5ʹ-ATT GAG GCC AGG ACA AGC AA-3ʹ
OSTβ 5ʹ-CCG AGT AGA GGA TGC AAC TCC-3ʹ 5ʹ-TTT GTT TTT CCG GTG GCA GC-3ʹ
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not differ between the groups (Supplementary Figure S2). Gene expression levels of CYP7A1 and CYP27A1, BA 
synthesis markers, did not differ among the groups (Supplementary Figure S3).
Intestinal gene expression of ASBT, a transporter responsible for the uptake of BAs from the lumen into 
the enterocyte, was increased in animals 24 hours after LPS administration (P < 0.05; Fig. 6) and tended to be 
increased 8 days after IA LPS administration, compared to control (P = 0.07; Fig. 6). Furthermore, intestinal 
mRNA expression levels of FGF19 (a hormone regulating bile acid synthesis), IBABP (required for efficient 
apical to basolateral transport of conjugated BAs in ileal enterocytes) and OSTα-β (transporters responsible for 
Figure 2.  Scoring of H&E slides on a 0 to 4 scale for degree of sinusoidal dilatation, shape and size of central 
veins and number and location of extramedullary hematopoietic clusters. Representative images of control 
(A), at day 8 after IA LPS administration (B) and at day 15 after LPS administration (C). Data are presented as 
median with IQR (D). D: Pathologic score with increased number of extramedullary hematopoietic clusters 
in the animals at day 8 and day 15 after IA LPS administration. Specifically, the increased extramedullary 
hematopoiesis, which manifests as clustering and conflation of hepatic erythropoiesis in the parenchyma, is 
indicated by white triangles (b + c). *P < 0.05 and **P < 0.01 compared to control.
Figure 3.  Relative mRNA expression of IL-8 (A), TNF-α (B) and IL-18 (C) in AU in the liver. Data are 
presented as median with IQR. A: IL-8 tended to increase 5 hours after IA LPS administration. P = 0.09 
compared to control. B: TNF-α mRNA levels tended to be increased 12 hours after IA LPS administration. 
P = 0.07 compared to control. C: IL-18 mRNA levels were increased at 24 hours and 2 days after IA LPS 
administration. *P = 0.05 and **P < 0.005 compared to control.
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BAs excretion from the enterocyte into the portal circulation) did not differ between the groups (Supplementary 
Figure S4). An overview of the EHC changes is depicted in Fig. 7. 
Intestinal inflammation after IA LPS exposure. Intestinal inflammation was detected by increased 
immunoreactivity of IBA1 (macrophages) in the terminal ileum of preterm lambs 2 days (P < 0.05; Fig. 8B,D) 
and 4 days (P = 0.09; Fig. 8C,D) after IA LPS administration, compared to control (Fig. 8A,D), which supports 
and extends earlier  findings24,28. Moreover, ileal IL-18 mRNA levels tended to be increased 24 hours after IA LPS 
administration, compared to control (P = 0.07; Fig. 9). 
Ethical approval. All procedures performed in studies involving animals were in accordance with the 
ethical standards of the institution at which the studies were conducted and ethical approval was obtained 
from the Animal Ethics Committees at The University of Western Australia (Perth, Australia; permit number: 
RA/3/100/928). All institutional and national guidelines for the care and use of laboratory animals were fol-
lowed.
Discussion
In this study, we evaluated the time-dependent effects of intra-uterine administration of LPS from 15 days to 
5 hours before premature delivery, on the liver and EHC of premature sheep.
Recent research showed that the fetal liver is an active immune organ with the ability of inducing an early and 
robust innate immune response activation, and immune activation is already initiated within 1 hour to 5 hours 
after an in utero inflammatory  challenge21. In our study, hepatic cytokine mRNA expression was increased from 
5 hours until 2 days after IA LPS administration and these time points overlap with the ongoing fetal systemic 
Figure 4.  Relative hepatic NTCP and BSEP gene expression in AU. Data are presented as median with IQR. 
NTCP (a) and BSEP (b) were decreased 12 hours after IA LPS administration. *P < 0.05 compared to control.
Figure 5.  tBAs concentrations in plasma in μmol/L. Data are presented as median with IQR. Increased tBAs 
concentration in animals 12 hours after IA LPS administration. *P < 0.05 compared to control.
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immune response, characterized by increased circulatory IL-6  levels5, suggesting that FIRS and local cytokine 
production in the liver are associated with each other. In accordance with these findings, chorioamnionitis-
induced hepatic inflammation was associated with FIRS in a similar ovine model in which fetuses were assessed 
at day 2 and day 14 after IA LPS  administration19. Accordingly, in utero, the liver might thus be one of the first 
organs to induce an innate immune response by early cytokine production as a result of chorioamnionitis.
An increased qualitative pathologic score of extramedullary hematopoiesis was observed in the liver paren-
chyma at 8 and 15 days after IA LPS administration. This increased score, reflecting clustered and conflated 
hepatic erythropoiesis in the parenchyma, is a hallmark of increased erythropoiesis in response to  inflammation26. 
Interestingly, in human stillborns, a similar histological pattern was strongly associated with  chorioamnionitis29, 
suggesting that antenatal inflammation alters fetal extramedullary hematopoiesis. Although hepatic TNF-α, IL-8 
and IL-18 levels have all been normalized at day 4 after IA LPS administration and no alterations in extramedul-
lary hematopoiesis were observed until day 8 after IA LPS administration, it is possible that the early hepatic 
cytokine response contributed to the altered fetal erythropoiesis at day 8 and day 15 after IA LPS administra-
tion. In addition, fetal ileal inflammation was observed in the current and previous  studies24 with the most 
evident signs of inflammation 2 days and 4 days after IA LPS exposure. Transport of inflammatory mediators 
from the gut to the liver via the portal vein may therefore also contribute to hepatic inflammation, illustrated by 
extramedullary hematopoiesis. As seen in a previous study, it has been shown that upon infection and resultant 
immune responses, various hematopoietic factors including TLR ligands and cytokines promote extramedullary 
hematopoiesis in the  liver30. Therefore, the ongoing fetal systemic inflammatory  response5 or the direct exposure 
to inflammatory mediators through the transport from the gut via the portal vein, or a combination of both are 
likely the cause of the observed altered fetal extramedullary hematopoiesis in our study. Interestingly, increased 
production of hepatic cytokines was also found in neonatal rats with NEC and correlated with the progression of 
intestinal damage during disease  development18. Since increased hepatic TNF-α, IL-8 and IL-18 levels preceded 
and showed overlap with intestinal inflammation, it is likely that the early hepatic cytokine response contributed 
to intestinal inflammation. Whether hepatic cytokines contribute to intestinal inflammation in utero via the 
periphery or the bile remains to be  elucidated18.
The important role of the liver and the gut-liver axis in NEC pathogenesis is further emphasized by the fact 
that elevated ileal BAs and an altered expression of several BAs transporters can contribute to the development of 
 NEC13–17,31. In our study, however, ileal BA levels were not changed. Only at 12 hours after IA LPS administration, 
plasma BA levels were increased, probably as a result of decreased NTCP expression. This indicates overflow of 
BAs returning via the portal circulation into the systemic circulation, with a rise in systemic BA levels as a result. 
Interestingly, cytokines are found to be key mediators in regulating hepatic expression of BA transporters during 
 inflammation32. Specifically, IL-6 can suppress NTCP and BSEP expression  levels10,32. The decreased expression 
of NTCP and BSEP in our study was thus most likely the result of the increased systemic IL-6  levels5. Moreover, 
it was shown that LPS activates cytokine production of Kupffer cells, such as TNF-α, which in turn bind to their 
receptors on hepatocytes resulting in reduced mRNA expression of several BAs  transporters10. Therefore, the 
increased hepatic TNF-α expression, in our study, might also have contributed to the decreased mRNA expres-
sion of NTCP and BSEP10,15,33. This suggests that both FIRS and liver inflammation are causally related to the 
changes in the hepatic BA transporters.
Reduced mRNA expression of various hepatic excretory BA transporters, e.g. BSEP, was observed in many 
animal models upon LPS treatment and also in patients with inflammation-induced  cholestasis10. The decreased 
Figure 6.  Relative gene expression of ASBT in AU in the terminal ileum. Data are presented as median with 
IQR. Increased ASBT expression in animals 24 hours and 8 days after IA LPS administration. *P < 0.05 compared 
to control. P = 0.07 compared to control.
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NTCP expression might thus be a compensatory mechanism to protect the liver against damage during sepsis 
as BAs have been shown to be hepatotoxic during  cholestasis11. Our results probably show an earlier disease 
state in which LPS induced sepsis not yet has progressed to cholestasis since hepatic BA levels were unchanged, 
indicating that these animals were not cholestatic. Another compensatory mechanism might be the unchanged 
BAs synthesis, which in the normal situation would be expected to increase to remain a constant BA pool.
Intestinal ASBT mRNA expression was increased in animals 24 hours after IA LPS administration, which 
might be a response to the decreased transport of BAs from the liver to the gut 12 hours after IA LPS administra-
tion. No changes in BAs concentrations in the ileum were observed at any of the time points, suggesting that the 
increased ASBT expression may be a compensatory mechanism to the postulated lower intraluminal BAs supply 
to keep a constant BA pool in the EHC, as ASBT is known to play a major role in BA  homeostasis34. Moreover, it 
might also be related to the increased cytokines such as ileal TNF-α and IL-18 levels, which in previous studies 
Figure 7.  An overview of the enterohepatic circulation (EHC) of bile acids (BAs) and changes herein related 
to FIRS and liver inflammation. CYP7A1 and CYP27A1 play a role in BAs production, which can be inhibited 
by FGF19. Physiologically, BAs are transported from hepatocytes via BSEP, via the gallbladder subsequently 
into the intestinal lumen. Most BAs are reabsorbed in the terminal ileum by ASBT. Following enterocyte 
uptake, BAs bind to IBABP to traverse the cytoplasm of epithelial cells. BAs exit the basolateral site of the 
enterocyte via OSTα-OSTβ. Via the portal vein, BAs are transported back to the liver. NTCP takes up the BAs 
into the hepatocyte to be recycled. Decreased expression of NTCP and BSEP and resultant increased plasma BA 
levels are associated with FIRS and liver inflammation. Increased ASBT expression may also be inflammation 
dependent, or a compensatory mechanism to the postulated lower intraluminal BAs supply to maintain a 
constant BA pool in the EHC.
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Figure 8.  IBA1 immunoreactivity in the terminal ileum. Representative images of control (A), at day 2 after IA 
LPS administration (B) and at day 4 after LPS administration (C). Data are presented as medium with IQR (D). 
D: Increased IBA1 positive surface area in animals 2 days and 4 days after IA LPS exposure. *P < 0.05 compared 
to control. P = 0.09 compared to control.
Figure 9.  Relative gene expression of IL-18 in AU in the terminal ileum. Data are presented as median with 
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have been shown to upregulate ASBT  expression35,36. Of note, intestinal BAs did not contribute to intestinal 
 inflammation24, as they were not increased.
The elevated BA levels in serum following IA LPS exposure were also measured in neonates with NEC in 
combination with depressed biliary BA levels, suggesting a failure of BA transport from the hepatocytes into 
the bile  canaliculi37. In addition, increased ASBT expression has been found in preterm infants and rodents with 
 NEC14,16. However, in our study, initial alterations to the EHC normalized after IA LPS administration, suggest-
ing that the duration of IA inflammation is important for the hepatic outcome. There is a defined window of 
vulnerability in which additional inflammatory hits, a premature born child is likely to encounter, might induce 
(additional) injury. This study highlights that the liver must be considered in neonatal care of preterm infants 
that suffered from inflammatory stress. Importantly, additional inflammation may have further impact on the 
liver and EHC and as a consequence the host in general. Based on our current findings, immune modulatory 
interventions such as nutrition and cytokine inhibitors might have the potential to improve neonatal wellbeing. 
In this context, timing of treatment initiation on the liver and EHC should be further studied.
A limitation of this study is the set-up in which the fixed moments of premature birth cannot exclude a 
potential influence of gestational age at start of IA infection. Furthermore, an unavoidable shortcoming of large 
animal studies is the relatively low number of animals per group.
In summary, in utero, the liver might be one of the first organs to induce an innate immune response by early 
cytokine production as a result of chorioamnionitis. An altered fetal erythropoiesis as a reaction to inflamma-
tion was detected at day 8 and day 15 after IA LPS administration that might be the result of hepatic cytokine 
production, ileal inflammation and ongoing FIRS. This ongoing fetal systemic inflammation and liver inflam-
mation most likely also caused the changes in the decreased expression of several hepatic BAs transporters and 
resultant increased plasma BA levels that were observed 12 hours after IA LPS administration. Initial alterations 
to the EHC normalized over time, suggesting that the duration of IA inflammation is important for the hepatic 
outcome. Since a premature born child is likely to encounter additional postnatal inflammatory hits that might 
induce (additional) injury, this study highlights that the liver must be considered in neonatal care of preterm 
infants that suffered from inflammatory stress.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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